BBC vs. QQQ
Compare and contrast key facts about Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Invesco QQQ (QQQ).
BBC and QQQ are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BBC is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Clinical Trials Index. It was launched on Dec 16, 2014. QQQ is a passively managed fund by Invesco that tracks the performance of the NASDAQ-100 Index. It was launched on Mar 10, 1999. Both BBC and QQQ are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BBC or QQQ.
Correlation
The correlation between BBC and QQQ is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BBC vs. QQQ - Performance Comparison
Key characteristics
BBC:
0.30
QQQ:
1.64
BBC:
0.66
QQQ:
2.19
BBC:
1.07
QQQ:
1.30
BBC:
0.17
QQQ:
2.16
BBC:
0.89
QQQ:
7.79
BBC:
11.77%
QQQ:
3.76%
BBC:
34.94%
QQQ:
17.85%
BBC:
-72.73%
QQQ:
-82.98%
BBC:
-60.17%
QQQ:
-3.63%
Returns By Period
In the year-to-date period, BBC achieves a 0.49% return, which is significantly lower than QQQ's 27.20% return. Over the past 10 years, BBC has underperformed QQQ with an annualized return of -0.51%, while QQQ has yielded a comparatively higher 18.36% annualized return.
BBC
0.49%
-6.09%
-3.67%
7.94%
-8.13%
-0.51%
QQQ
27.20%
3.08%
8.34%
27.81%
20.44%
18.36%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BBC vs. QQQ - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than QQQ's 0.20% expense ratio.
Risk-Adjusted Performance
BBC vs. QQQ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BBC vs. QQQ - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 0.99%, more than QQQ's 0.43% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 0.99% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.04% | 0.00% | 0.51% | 0.00% | 0.00% |
QQQ Invesco QQQ | 0.43% | 0.62% | 0.80% | 0.43% | 0.55% | 0.74% | 0.91% | 0.84% | 1.06% | 0.99% | 1.41% | 1.02% |
Drawdowns
BBC vs. QQQ - Drawdown Comparison
The maximum BBC drawdown since its inception was -72.73%, smaller than the maximum QQQ drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for BBC and QQQ. For additional features, visit the drawdowns tool.
Volatility
BBC vs. QQQ - Volatility Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 11.33% compared to Invesco QQQ (QQQ) at 5.29%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.